Eczema Free Forever™

Pipeline topical reduces epidermolysis bullosa blistering

Castle Creek Pharmaceuticals announced in June 2017 that the first patient had enrolled in its phase 2/3 study assessing the safety and efficacy of its pipeline diacerein 1% ointment to treat epidermolysis bullosa simplex.
Dermatology Times – Dermatology

Eczema Free Forever™